ly3437943
Showing 1 - 13 of 13
Healthy Trial in Daytona Beach (LY3437943)
Not yet recruiting
- Healthy
- LY3437943
-
Daytona Beach, FloridaLabCorp CRU, Inc
Jul 17, 2023
Overweight Trial in South Miami, San Antonio (LY3437943, Ethinyl Estradiol, Drospirenone)
Not yet recruiting
- Overweight
- LY3437943
- +2 more
-
South Miami, Florida
- +1 more
Sep 11, 2023
Healthy Trial in Miami, San Antonio, Salt Lake City (LY3437943, Test, Reference)
Not yet recruiting
- Healthy
- LY3437943
- +2 more
-
Miami, Florida
- +2 more
Aug 16, 2023
Healthy, Hepatic Insufficiency Trial in DeLand, Miami, San Antonio (LY3437943)
Not yet recruiting
- Healthy
- Hepatic Insufficiency
- LY3437943
-
DeLand, Florida
- +3 more
Jun 15, 2023
Overweight, Obesity Trial in Cheng Du, Beijing (LY3437943, Placebo)
Recruiting
- Overweight
- Obesity
- LY3437943
- Placebo
-
Cheng Du, Sichuan, China
- +1 more
Dec 8, 2022
Obesity Trial in Daytona Beach, Dallas (LY3437943, Midazolam, Warfarin)
Active, not recruiting
- Obesity
- LY3437943
- +3 more
-
Daytona Beach, Florida
- +1 more
Nov 9, 2022
Healthy, Renal Insufficiency Trial in Orlando, Saint Paul (LY3437943)
Recruiting
- Healthy
- Renal Insufficiency
- LY3437943
-
Orlando, Florida
- +1 more
Dec 8, 2022
Diabetes, Type 2 Trial in Japan (LY3437943, Placebo)
Completed
- Diabetes Mellitus, Type 2
- LY3437943
- Placebo
-
Suita-shi, Osaka, Japan
- +3 more
Aug 19, 2022
Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)
Not yet recruiting
- Overweight or Obesity
- +2 more
- LY3437943
- Placebo
-
Canoga Park, California
- +19 more
Jun 30, 2023
Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)
Active, not recruiting
- Obesity
- Overweight
- LY3437943
- Placebo
-
Scottsdale, Arizona
- +27 more
May 10, 2022
Diabetes, Type 2 Trial in United States (LY3437943, Dulaglutide, Placebo)
Completed
- Diabetes Mellitus, Type 2
- LY3437943
- +2 more
-
Anaheim, California
- +3 more
Jan 18, 2021
Type 2 Diabetes Trial in Puerto Rico, United States (LY3437943, Dulaglutide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- LY3437943
- +2 more
-
Sheffield, Alabama
- +42 more
Feb 18, 2022
Healthy Trial in Singapore (LY3437943, Placebo)
Completed
- Healthy
- LY3437943
- Placebo
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Aug 5, 2019